← Back to Search

Imaging

Electromagnetic Acoustic Imaging for Liver Cancer

N/A
Waitlist Available
Led By Chirag Patel, MD
Research Sponsored by Enhanced Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

Summary

A single-centre, industry sponsored, proof-of-concept pilot study to assess the feasibility of Electromagnetic Acoustic Imaging (EMA) as an imaging platform in the visualization of hepatic tumours.

Eligible Conditions
  • Liver Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
EMA (colour scale) images will be compared to baseline US grey-scale images for a specific target lesion, as determined by standard of care imaging (US, CT, MRI or PET) and/or histologically proven lesion in a given subject.
Secondary study objectives
US grey-scale and EMA colour maps will be obtained from both target liver lesions and background liver tissue from the same subject and compared.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Electromagnetic Acoustic ImagingExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Enhanced MedicalLead Sponsor
Sunnybrook Health Sciences CentreOTHER
671 Previous Clinical Trials
1,564,605 Total Patients Enrolled
1 Trials studying Liver Cancer
8,000 Patients Enrolled for Liver Cancer
Chirag Patel, MDPrincipal InvestigatorSunnybrook Health Sciences Centre
~3 spots leftby Sep 2025